Conference item : Abstract
Negative control time window to identify residual confounding in comparative effectiveness study: An example of bisphosphonate use and risk of fracture
- Publication status:
- Published
- Peer review status:
- Reviewed (other)
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 104.6KB, Terms of use)
-
- Publisher copy:
- 10.1002/pds.4629
Authors
- Publisher:
- Wiley
- Host title:
- Pharmacoepidemiology and Drug Safety
- Journal:
- 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE 2018) More from this journal
- Volume:
- 27
- Issue:
- S2
- Pages:
- 161
- Publication date:
- 2018-08-17
- Acceptance date:
- 2018-05-08
- DOI:
- EISSN:
-
1099-1557
- ISSN:
-
1053-8569
- Subtype:
-
Abstract
- Pubs id:
-
pubs:847094
- UUID:
-
uuid:68f44eee-86c2-4278-b2be-e622a26cd4c7
- Local pid:
-
pubs:847094
- Source identifiers:
-
847094
- Deposit date:
-
2018-05-10
- ARK identifier:
Terms of use
- Copyright holder:
- Robinson et al
- Copyright date:
- 2018
- Notes:
- © 2018 The Authors. Pharmacoepidimeology and Drug Safety © 2018 John Wiley & Sons, Ltd. This paper was presented at the 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE 2018), 22-26 August 2018, Prague, Czech Republic. This is the accepted manuscript version of the article. The final version is available online from Wiley at: https://doi.org/10.1002/pds.4629
If you are the owner of this record, you can report an update to it here: Report update to this record